Endocrinology · Thyroid Neoplasms
The facts most likely to be tested
Follicular thyroid carcinoma is characterized by hematogenous spread to distant sites, most commonly the lungs and bones.
Fine-needle aspiration (FNA) cannot distinguish between follicular adenoma and follicular carcinoma because the diagnosis requires evidence of capsular or vascular invasion.
The definitive diagnosis of follicular thyroid carcinoma is made only after surgical excision and histopathologic examination of the entire thyroid nodule.
Follicular thyroid carcinoma is more common in regions with dietary iodine deficiency.
The PAX8-PPARγ fusion protein is a specific molecular translocation frequently associated with the pathogenesis of follicular thyroid carcinoma.
Post-thyroidectomy management often involves radioactive iodine (I-131) ablation to treat residual tissue and distant metastases.
Serum thyroglobulin levels serve as a highly sensitive tumor marker for monitoring recurrence or metastatic disease following total thyroidectomy.
Vignette unlocked
A 52-year-old woman presents to the clinic for a routine follow-up regarding a persistent thyroid nodule. She underwent a fine-needle aspiration biopsy three months ago, which showed follicular cells but was indeterminate for malignancy. She now reports a new, dull ache in her left hip. Physical examination reveals a firm, non-tender, solitary thyroid nodule. A skeletal survey demonstrates a lytic bone lesion in the left ilium.
What is the most likely diagnosis?
Follicular thyroid carcinoma
The presence of a lytic bone lesion in a patient with a follicular thyroid nodule is highly suggestive of hematogenous metastasis, which is the classic presentation of follicular thyroid carcinoma compared to the lymphatic spread of papillary thyroid carcinoma.
Full handout
High yield triage
Etiology / Epidemiology
Second most common thyroid malignancy; associated with iodine deficiency and follicular adenoma.
Clinical Manifestations
Presents as a solitary, painless thyroid nodule; hematogenous spread to bone and lung.
Diagnosis
Fine-needle aspiration (FNA) cannot distinguish from adenoma; requires surgical excision for diagnosis.
Treatment
Total thyroidectomy followed by radioactive iodine (I-131) ablation.
Prognosis
Better prognosis than anaplastic; monitor thyroglobulin levels for recurrence.
Full handout
Epidemiology & Etiology
Occurs more frequently in areas of iodine deficiency. It is the second most common thyroid cancer, typically affecting patients in the 40-60 age range. Unlike papillary carcinoma, it is more common in women and shows a distinct preference for hematogenous spread.
Pertinent Anatomy
Arises from the follicular epithelium of the thyroid gland. The tumor is typically encapsulated, which is a critical feature for surgical pathology. Its proximity to the recurrent laryngeal nerve necessitates careful surgical dissection to avoid vocal cord paralysis.
Pathophysiology
Characterized by the presence of follicular cells arranged in a follicular pattern. Malignancy is defined by capsular or vascular invasion, which cannot be determined by cytology alone. Genetic mutations often involve the RAS oncogene or PAX8-PPARγ fusion proteins.
Clinical Manifestations
Patients present with a slow-growing, painless thyroid nodule. Rapid enlargement or hoarseness suggests local invasion or malignancy. Distant metastases to bone and lung are more common than lymph node involvement, which is a key differentiator from papillary carcinoma.
Diagnosis
Fine-needle aspiration (FNA) is the initial test but is limited by the inability to distinguish between follicular adenoma and carcinoma. Surgical excision (lobectomy or thyroidectomy) is the gold standard for definitive diagnosis via histopathologic examination of the capsule.
Treatment
Primary management is total thyroidectomy. Post-operative radioactive iodine (I-131) ablation is indicated to destroy residual tissue and treat occult metastases. Levothyroxine is used for thyroid-stimulating hormone (TSH) suppression to prevent tumor growth.
Prognosis
Prognosis is generally favorable but depends on the degree of invasion. Thyroglobulin levels serve as a sensitive tumor marker for monitoring recurrence. Distant metastasis is the most significant factor impacting long-term survival.
Differential Diagnosis
Papillary Thyroid Carcinoma: presence of psammoma bodies and lymphatic spread
Follicular Adenoma: benign, lacks capsular or vascular invasion
Medullary Thyroid Carcinoma: elevated calcitonin levels
Anaplastic Thyroid Carcinoma: rapid growth, highly aggressive, elderly patients
Thyroid Lymphoma: associated with Hashimoto thyroiditis